Evidence map›Paper›PMID 20951714›Full record

ArticlePhysiology & behavior2011

Resistance of male Sprague-Dawley rats to sucrose-induced obesity: effects of 18-methoxycoronaridine.

Olga D Taraschenko, Isabelle M Maisonneuve, Stanley D Glick

Abstract read
In one paragraph

Article in Physiology & behavior, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Olga D TaraschenkoCenter for Neuropharmacology and Neuroscience, Albany Medical College, Albany, NY, United States. tarasco@mail.amc.edu
Isabelle M Maisonneuve
Stanley D Glick
Albany Medical Center Hospital · US

Funding

DIENCEPHALIC MECHANISMS OF DRUG ABUSER01DA016283 · NIDA · ALBANY MEDICAL COLLEGE · PI GLICK, STANLEY D · 2004 to 2008
$1.3M
NIDA NIH HHS DA 016283NIDA NIH HHS R01 DA016283
6 · The paper itself

Abstract

Evidence suggests that the development of obesity in males and females might be mediated by distinct mechanisms, warranting different treatment approaches. In previous studies from this laboratory, a high sucrose diet induced excessive weight gain in female Sprague-Dawley rats and administration of a selective antagonist of α3β4 nicotinic receptors, 18-methoxycoronaridine (18-MC), prevented this form of obesity. In the present study similar parameters were studied in male rats by using an identical experimental protocol. The effects of repeated administration of 18-MC on body weight gain, deposition of fat, consummatory behavior and biochemical markers of obesity in male rats were also assessed. In contrast to females, males consuming ad libitum quantities of sucrose solution (30%) in combination with normal chow did not become obese; they did not gain excessive weight nor show excessive fat deposition. Repeated administration of 18-MC (20mg/kg, i.p.) attenuated weight gain in both sucrose-consuming and control animals without altering food or fluid intake. The present results indicate that males and females are differentially responsive to high carbohydrate-diet obesity. Such gender disparities could be secondary to sex-specific alterations in cholinergic mechanisms of feeding and body weight regulation.

Indexed as

Analysis of VarianceAnimalsAnti-Obesity AgentsBlood GlucoseBody WeightCholesterolDisease Models, AnimalDrinkingDrug Administration ScheduleEatingFemaleIbogaineMaleObesityRatsRats, Sprague-Dawley18-methoxycoronaridineAnti-Obesity AgentsBlood GlucoseCholesterolIbogaineSucrase

Identifiers

PMID20951714
PMCPMC4575504
OpenAlexW1982026321

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.